APOE and atherosclerosis: However, the fact that the genetic ablation of miR-33 protects against the progression of atherosclerosis in apoE−/− mice suggests that long-term anti-miR-33 therapy should be beneficial for treating atherosclerotic vascular disease (Horie et al, 2012).